TickerGuard
Buy Day today: Poor (52) Mixed market breadth · today: Core PCE (August) ≈
TKNO

Alpha Teknova Inc

Healthcare · Drug Manufacturers - Specialty & Generic

9.30$ +4.0% vs. previous close Closing price · As of: Sep 24, 2026

Statements

Balance Sheet

All figures as the change versus the prior period, in percent. Periods without a positive comparison base stay empty.

Tick rows to compare them in a chart (up to 4)

Balance Sheet TKNO
Line item 2019 2020 2021 2022 2023 2024 2025
– +7.5% +164.7% -8.6% -15.5% -7.6% -12.8%
– +6.5% +516.6% -39.6% -25.3% -6.3% -19.3%
– -20.0% +2,540.1% -51.7% -32.6% -87.0% +59.4%
– -47.0% +1,607.3% -51.7% -32.6% +6.7% -80.6%
– +120.0% -10.9% -26.8% -7.8% +9.2% +7.1%
– +39.6% +50.6% +127.0% -5.3% -41.3% +3.7%
– +83.6% +197.9% +139.2% – – –
– +0.0% +0.0% -100.0% – – –
– -5.5% -5.8% -6.1% -18.9% -8.1% -8.8%
– -77.0% +121.9% +124.7% -26.4% -5.6% -4.3%
– -29.0% +95.4% +40.4% -18.4% +26.3% -32.8%
– – – +1,011.5% -18.9% +224.2% -67.9%
– +112.9% +37.5% +8.9% -39.0% -44.7% +67.0%
– – – +85.1% -39.7% -28.7% +39.0%
– +305.9% +173.3% -30.2% -9.9% -8.5% -16.5%
– – -432.8% – – – –
– +9.3% +604.4% +0.3% +13.3% +46.9% +14.4%

Data as of: September 24, 2026 · Source: fundamental data & SEC filings (annual and quarterly reports, 10-K/10-Q)

Note: pure fact-based analysis, not investment advice and not a solicitation to buy or sell. All figures without guarantee.

Was this page helpful to you?